ID
24457
Descrizione
Module 21- GSK study: Ropinirole in RLS patients 101468/243 - Evening Visits for Orthostatic Vital Signs, Unscheduled Week Study ID: 101468/243 Clinical Study ID: 101468/243 Study Title: A 52 Week Open-Label Extension Study of the Long-Term Safety of Ropinirole in Subjects Suffering from Restless Legs Syndrome (RLS) Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: N/A Sponsor:GlaxoSmithKline Collaborators: N/A Phase: Phase 3 Study Recruitment Status: Completed Generic Name: ropinirole Trade Name: Modutab,ZIPEREVE,ZEPREVE,REPREVE,ADARTREL,REQUIP,Zygara; Zygara,ZIPEREVE,ZEPREVE,Requip Depot,REQUIP,REPREVE,Modutab,ADARTREL Study Indication: Restless Legs Syndrome
Keywords
versioni (1)
- 01/08/17 01/08/17 -
Titolare del copyright
glaxoSmithKline
Caricato su
1 agosto 2017
DOI
Per favore, per richiedere un accesso.
Licenza
Creative Commons BY-NC 3.0
Commenti del modello :
Puoi commentare il modello dati qui. Tramite i fumetti nei gruppi di articoli e articoli è possibile aggiungere commenti a quelli in modo specifico.
Commenti del gruppo di articoli per :
Commenti dell'articolo per :
Per scaricare i modelli di dati devi essere registrato. Per favore accesso o registrati GRATIS.
GSK study: Ropinirole in RLS patients 101468/243 - Evening Visits for Orthostatic Vital Signs, Unscheduled Week 2
GSK study: Ropinirole in RLS patients 101468/243 - Evening Visits for Orthostatic Vital Signs, Unscheduled Week 2
Descrizione
Medical procedures
Alias
- UMLS CUI-1
- C0199171
Descrizione
Concomitant Medication
Alias
- UMLS CUI-1
- C2347852
Descrizione
Adverse experience
Alias
- UMLS CUI-1
- C0559546
Descrizione
Instructions for the investigator
Alias
- UMLS CUI-1
- C0302828
- UMLS CUI-2
- C0035173
Descrizione
Guided by the CGI Efficacy Index (below) determine dose level of study medication to be dispensed. Complete the Study Medication and Compliance Section. If the patient’s dose has been increased at this clinic visit: a) Instruct the patient to return to the clinic this evening or remain to perform orthostatic vital signs*: - 2 sets of pre-dose orthostatic blood pressure and pulse - Patient takes evening dose in the clinic - One set of 2 hour post-dose orthostatic blood pressure and pulse Instruct the patient to take the appropriate number of tablet(s), at the same time, no earlier than 3 hours prior to and no later than one hour prior to bedtime (except on the first night of each new dose increase). Patient must return the bottle(s) with any unused medication at the next visit. Arrange for the patient to return for next scheduled clinic visit. * Where possible this visit should be performed in the evening with dosing approximately 8:00 P.M. However, for scheduling convenience, this visit (including dosing) may occur during the afternoon hours (as late in the day as possible) to accomodate the collection of orthostatic blood pressure/pulse assessments during the normal clinic hours.
Tipo di dati
text
Alias
- UMLS CUI [1,1]
- C0302828
- UMLS CUI [1,2]
- C0035173
Descrizione
Clinical Global impression
Alias
- UMLS CUI-1
- C3639708
Descrizione
Dose change between scheduled visits
Alias
- UMLS CUI-1
- C1707811
Descrizione
Orthostatic vital signs - instructions
Alias
- UMLS CUI-1
- C0518766
- UMLS CUI-2
- C1442085
Descrizione
ONLY TAKE ORTHOSTATIC VITAL SIGNS IF A DOSE INCREASE OCCURS Instructions: Semi-supine measurements will be made after the patient has been resting semi-supine for at least 10 minutes and erect measurements will be taken after the patient has been standing for a period of 1 minute. • The blood pressure cuff must be placed on the same arm throughout the study. • Ideally, the same study nurse/medical professional should conduct all the blood pressure/pulse measurements for each clinic visit and each patient throughout the study. • Pre-dose orthostatic measurements will commence approximately 30 minutes prior to dosing and each set will be separated by 10 minutes rest in the semi-supine position. • Two sets of stable, consecutive pre-dose semi-supine and erect blood pressure measurements as well as two sets of pulse rate measurements will be taken. Stable is defined as three measurements within +15mmHg of the lowest measurement. • One set of orthostatic blood pressure and pulse measurements will be taken 2 hours post dose.
Tipo di dati
text
Alias
- UMLS CUI [1,1]
- C0518766
- UMLS CUI [1,2]
- C1442085
Descrizione
Pre-Dose Reading
Alias
- UMLS CUI-1
- C1522609
- UMLS CUI-2
- C0439565
Descrizione
Pre-dose reading
Tipo di dati
integer
Alias
- UMLS CUI [1,1]
- C1522609
- UMLS CUI [1,2]
- C0439565
Descrizione
Pre-Dose Reading: after 10 min in semi-supine position. 40 min prior to dosing.
Tipo di dati
time
Alias
- UMLS CUI [1,1]
- C0518766
- UMLS CUI [1,2]
- C0040223
Descrizione
Pre-Dose Reading: after 10 min in semi-supine position. 40 min prior to dosing.
Tipo di dati
integer
Unità di misura
- mmHg
Alias
- UMLS CUI [1]
- C0871470
Descrizione
Pre-Dose Reading: after 10 min in semi-supine position. 40 min prior to dosing.
Tipo di dati
integer
Unità di misura
- mmHg
Alias
- UMLS CUI [1]
- C0428883
Descrizione
Pre-Dose Reading: after 10 min in semi-supine position. 40 min prior to dosing.
Tipo di dati
integer
Unità di misura
- beats/min
Alias
- UMLS CUI [1]
- C0232117
Descrizione
Pre-Dose Reading: after erect for 1 min. 40 min prior to dosing.
Tipo di dati
time
Alias
- UMLS CUI [1,1]
- C0518766
- UMLS CUI [1,2]
- C0040223
Descrizione
Pre-Dose Reading: after erect for 1 min. 40 min prior to dosing.
Tipo di dati
integer
Unità di misura
- mmHg
Alias
- UMLS CUI [1]
- C0871470
Descrizione
Pre-Dose Reading: after erect for 1 min. 40 min prior to dosing.
Tipo di dati
integer
Unità di misura
- mmHg
Alias
- UMLS CUI [1]
- C0428883
Descrizione
Pre-Dose Reading: after erect for 1 min. 40 min prior to dosing.
Tipo di dati
integer
Unità di misura
- beats/min
Alias
- UMLS CUI [1]
- C0232117
Descrizione
Time of dose
Alias
- UMLS CUI-1
- C0013227
- UMLS CUI-2
- C0040223
Descrizione
2 hours Post-Dose Reading 1
Alias
- UMLS CUI-1
- C1522609
- UMLS CUI-2
- C0439572
Descrizione
Post-Dose Reading 1: after 10 min in semi-supine position. 2 hours post-dose.
Tipo di dati
time
Alias
- UMLS CUI [1,1]
- C0518766
- UMLS CUI [1,2]
- C0040223
Descrizione
Post-Dose Reading 1: after 10 min in semi-supine position. 2 hours post-dose.
Tipo di dati
integer
Unità di misura
- mmHg
Alias
- UMLS CUI [1]
- C0871470
Descrizione
Post-Dose Reading 1: after 10 min in semi-supine position. 2 hours post-dose.
Tipo di dati
integer
Unità di misura
- mmHg
Alias
- UMLS CUI [1]
- C0871470
Descrizione
Post-Dose Reading 1: after 10 min in semi-supine position. 2 hours post-dose.
Tipo di dati
integer
Unità di misura
- beats/min
Alias
- UMLS CUI [1]
- C0232117
Descrizione
Post-Dose Reading 1: after erect for 1 min. 2 hours post-dose.
Tipo di dati
time
Descrizione
Post-Dose Reading 1: after erect for 1 min. 2 hours post-dose. in mmHg; systolic/diastolic
Tipo di dati
integer
Unità di misura
- mmHg
Alias
- UMLS CUI [1]
- C0871470
Descrizione
Post-Dose Reading 1: after erect for 1 min. 2 hours post-dose.
Tipo di dati
integer
Unità di misura
- mmHg
Alias
- UMLS CUI [1]
- C0428883
Descrizione
Pre-Dose Reading 1: after erect for 1 min. 2 hours post-dose.
Tipo di dati
integer
Unità di misura
- beats/min
Alias
- UMLS CUI [1]
- C0232117
Similar models
GSK study: Ropinirole in RLS patients 101468/243 - Evening Visits for Orthostatic Vital Signs, Unscheduled Week 2
C0008972 (UMLS CUI-2)
C0008972 (UMLS CUI [1,2])
C0035173 (UMLS CUI-2)
C0035173 (UMLS CUI [1,2])
C1442085 (UMLS CUI-2)
C1442085 (UMLS CUI [1,2])
C0439565 (UMLS CUI [1,2])
C0040223 (UMLS CUI [1,2])
C0040223 (UMLS CUI [1,2])
C0040223 (UMLS CUI [1,2])
C0439572 (UMLS CUI-2)
C0040223 (UMLS CUI [1,2])